-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Fusion Pharmaceuticals Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2022 to 2023.
- Fusion Pharmaceuticals Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $1.63M, a 48.6% increase year-over-year.
- Fusion Pharmaceuticals Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $4.62M, a 192% increase from 2022.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)